News & Views
-
Matthew Segall
Collaboration to advance Global Drug Discovery Infrastructure
Nov 26 2020 Read 273 Times
Drug discovery software developer Optibrium has announced a collaboration with US-based MSD which has adopted the Cambridge, UK company's StarDrop™ software as a central component of their cheminformatics infrastructure. The partnership will also include the joint development of new tools, to improve cycle times, efficiency and productivity of the drug discovery process.
Dr Matthew Segall, Optibrium’s CEO, commented, “We are delighted to enter this collaboration to contribute to MSD’s world-leading cheminformatics infrastructure. We look forward to working together to advance new tools based around StarDrop to further refine our compound design platform.”
MSD is a tradename of Merck & Co Inc, Kenilworth NJ
Further information www.online
Digital Edition
Lab Asia December 2020
December 2020
In This Edition Articles - The Movement Towards More Comprehensive Testing of Mycotoxins in Cannabis - Addressing proper HACCP implementation - Micropatterning: The art of micro-controlling...
View all digital editions
Events
Jan 20 2021 Tokyo, Japan & online
Jan 23 2021 Digital Event
Jan 26 2021 Virtual event
Filtech - POSTPONED. NEW DATES TBC
Feb 23 2021 Cologne, Germany
Feb 28 2021 Virtual event
Reader comments
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.